Why the study?
Papillary fibroelastoma is a rare benign cardiac tumor with a high tendency for fatal systemic or pulmonary embolization, prompting the authors to present their management experience.
Surgical excision of valvular papillary fibroelastomas is safe and effective, with no mortality observed in this small series, though neurological complications can occur.
Answers are grounded in this paper and cite their sources.
Small PFE case series supports surgical safety via sternotomy or minimally invasive approaches; leaves open optimal timing and embolization risk stratification.
Objective Papillary fibroelastoma(PFE) is the second most common benign cardiac tumors.Although very rare but it has unique histopathological structure making it with higher tendency to embolization with fatal systemic or pulmonary complicationswe present our experience in managing is very rare cardiac tumors . Surgery is the definitive treatment it can be done safely through conventional sternotomy or minimal invasive approachMethods From 2008 TO 2020 , 7 Patients have been operated for of valvular papillary fibroelastoma All are managed surgical base .4 aortic and 3 mitral cases.Surgical approach according to surgeon preferenceResultsAll patients treated surgical with excision of the mass, neurological cerebral vascular accident are the main complications. one case require Aortic valve replacement. Other mitral cases need ring annuloplasty for associated sever Mitral regurgitation. No mortality . Estimated ICU stay 30±7 hrs. and in patient hospital stay 5± 1.5 days.Conclusions papillary fibroelastoma(PFE) although benign but has fatal outcome secondary to higher tendency to embolize. High clinical suspicious should be raised correlated with diagnostic tool TTE. Surgery is the definitive treatment can be done conventionally or minimal invasive approach safely
No takes yet. Share an insight, caveat, or question.
kassem et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: